STOCK TITAN

NewGenIVF Group (Nasdaq: NIVF) values 13% K25.ai stake near US$26M

(Neutral)
(Neutral)
Form Type
6-K

Rhea-AI Filing Summary

NewGenIVF Group Limited reports net profit attributable to shareholders of US$9.9 million for the year ended December 31, 2025, and net assets of about US$25.98 million. The company also highlights an agreed 13% stake in K25.ai, subject to completion of share purchase agreements.

Based on a current implied K25.ai valuation of US$200 million, this stake is valued at about US$26 million and is expected to generate an unrealized gain of approximately US$8.5 million, which NewGen views as strengthening its balance sheet. After a planned issuance of 2,500,000 Class A ordinary shares, total outstanding Class A shares are expected to reach about 5,900,000.

Positive

  • NewGenIVF’s agreed 13% stake in K25.ai is valued at about US$26 million, implying an expected unrealized gain of approximately US$8.5 million, which the company views as a meaningful enhancement to its balance sheet.
  • The company reports US$9.9 million in net profit attributable to shareholders and US$25.98 million in net assets for 2025, supporting its characterization of a strong financial foundation.

Negative

  • None.
Net profit attributable to shareholders US$9.9 million For the fiscal year ended December 31, 2025
Net assets US$25.98 million As of December 31, 2025
Implied K25.ai valuation US$200 million Current implied valuation based on recently closed Series A round
Value of 13% K25.ai stake US$26 million Approximate value of NewGenIVF’s agreed stake, subject to completion
Expected unrealized gain US$8.5 million Expected gain from appreciation of the K25.ai investment
Planned Class A share issuance 2,500,000 shares Class A ordinary shares announced for issuance on July 27, 2026
Expected total Class A shares outstanding 5,900,000 shares Expected total outstanding after completion of the share issuance
unrealized gain financial
"generating an expected unrealized gain of approximately US$8.5 million"
An unrealized gain is the increase in value of an investment that you still hold and have not sold, so the profit exists on paper but hasn’t been converted into cash. Like a balloon that has inflated but hasn’t been popped, it raises your reported net worth and signals how well an investment is performing, yet it can fall before you sell; investors watch unrealized gains to decide when to lock in profits, manage risk, and plan for taxes.
net assets financial
"with net assets of approximately US$25.98 million as of that date"
Net assets represent the total value of what an organization owns minus what it owes. Think of it like a person’s belongings after paying off any debts—what remains is their net worth. For investors, net assets indicate the overall financial strength of a company or fund, showing how much value is available to shareholders.
Series A investment round financial
"based on K25.ai’s recently closed Series A investment round"
A Series A investment round is the first significant venture capital funding round a startup raises after initial seed money, where professional investors buy preferred equity to help the company scale its product, team, and market reach. Think of it like a gardener buying more tools and seeds to grow a small plot into a larger farm; for investors it signals a company has moved beyond concept and is being bet on for measurable growth and future value.
decentralized-finance financial
"focused on digital asset and decentralized-finance solutions"
share dilution financial
"and share dilution and capital markets issuance risk"
forward-looking statements regulatory
"This press release contains forward-looking statements within the meaning"
Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What net profit did NewGenIVF Group (NIVF) report for 2025?

NewGenIVF reported net profit attributable to shareholders of US$9.9 million for the fiscal year ended December 31, 2025. The company also reported net assets of about US$25.98 million as of that date, which it describes as providing a strong financial foundation.

How large is NewGenIVF Group’s (NIVF) stake in K25.ai and what is it worth?

NewGenIVF has agreed to acquire a 13% stake in K25.ai, subject to completion of share purchase agreements. Based on a current implied K25.ai valuation of US$200 million, the company estimates its stake is now valued at approximately US$26 million.

What unrealized gain does NewGenIVF Group (NIVF) expect from its K25.ai investment?

The company estimates an expected unrealized gain of approximately US$8.5 million from the appreciation of its agreed K25.ai stake. This is based on a current implied valuation of US$200 million for K25.ai and the corresponding approximate US$26 million value of NewGenIVF’s 13% interest.

How many NewGenIVF Group (NIVF) shares are expected to be outstanding after the latest issuance?

Upon completion of a previously announced issuance of 2,500,000 Class A ordinary shares, NewGenIVF expects its total outstanding Class A ordinary share count to reach approximately 5,900,000. This change is expected to affect the company’s capitalization and share base.

How does the K25.ai investment affect NewGenIVF Group’s (NIVF) balance sheet?

NewGenIVF states that the appreciation in its agreed 13% K25.ai stake, now valued at about US$26 million, generates an expected unrealized gain of approximately US$8.5 million. The company believes this represents a meaningful enhancement to its balance sheet strength.

What businesses and strategy does NewGenIVF Group (NIVF) describe?

NewGenIVF describes itself as a technology-forward, diversified growth company operating in real estate (NewGenProperty), digital asset and decentralized-finance solutions (NewGenDigital), and health and longevity products (NewGenSup), alongside a legacy IVF and assisted reproductive treatment business across Asia.

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 UNDER

THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of July 2026

 

Commission File Number: 001-42004

 

NEWGENIVF GROUP LIMITED

 

36/39-36/40, 13th Floor, PS Tower

Sukhumvit 21 Road (Asoke)

Khlong Toei Nuea Sub-district

Watthana District, Bangkok 10110

Thailand

(Address of Principal Executive Offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

 

Form 20-F ☒         Form 40-F ☐

 

 

  

 

 

EXPLANATORY NOTE

 

Information Contained in this Form 6-K Report

 

Attached as Exhibit 99.1 is a copy of press release of NewGenIvf Group Limited dated July 30, 2026.

 

1

 

 

EXHIBIT INDEX

 

Exhibit   Description
99.1   Press release

 

2

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Date: July 30, 2026

 

  NewGenIvf Group Limited
     
  By: /s/ Wing Fung Alfred Siu
  Name:  Wing Fung Alfred Siu
  Title: Chairman of the Board and Director

 

3

Exhibit 99.1

 

NewGen Provides Update on K25.ai Investment and Strengthened Financial Position

 

NewGen’s total shares outstanding count expected to reach 5.9 million following recently announced share issuance, bolstering market capitalization

 

NewGen’s agreed 13% stake in K25.ai is now valued at approximately US$26 million, based on K25.ai’s recently closed Series A investment round, representing an unrealized gain of about US$8.5 million

 

BANGKOK, July 30, 2026 – NewGenIVF Group Limited (Nasdaq: NIVF) (“NewGen” or the “Company”), a technology-driven, diversified growth company, today provided an update on its strategic investment in K25.ai and the related impact on the Company’s capitalization and financial position.

 

NewGen reported net profit attributable to shareholders of US$9.9 million for the fiscal year ended December 31, 2025, with net assets of approximately US$25.98 million as of that date. The Company’s financial position has been further strengthened in 2026 by the appreciation in value of its investment in K25.ai.

 

Based on a current implied valuation of US$200 million for K25.ai, the Company’s agreed 13% stake, which remains subject to completion of the acquisitions in accordance with the applicable share purchase agreements, is now valued at approximately US$26 million, generating an expected unrealized gain of approximately US$8.5 million. The Company believes this appreciation represents a meaningful enhancement to its balance sheet and reflects the continued growth trajectory of K25.ai since the initial investment was made.

 

Upon completion of the issuance of 2,500,000 Class A ordinary shares as announced on July 27, 2026, NewGen’s total outstanding Class A ordinary share count is expected to reach approximately 5,900,000.

 

Alfred Siu, Founder, Chairman and CEO of NewGen, commented, “Our 2025 results, including US$9.9 million in net profit and US$25.98 million in net assets, reflect a strong financial foundation. The step-up in K25.ai’s implied valuation to US$200 million brings our 13% stake to approximately US$26 million and generates an expected unrealized gain of approximately US$8.5 million, further strengthening our balance sheet as we execute on our growth strategy.”

 

About NewGen

 

NewGenIVF Group Limited is a technology-forward, diversified growth company pursuing opportunities across real estate development, digital asset innovation, and reproductive health solutions. The Company operates through NewGenProperty, focused on real estate development projects in Ras Al Khaimah, United Arab Emirates; NewGenDigital, focused on digital asset and decentralized-finance solutions; and NewGenSup, focused on health and longevity products and solutions. NewGenIVF’s legacy business includes IVF and assisted reproductive treatment services across Asia. To learn more, visit www.nivf.global. Information contained on, or accessible through, the Company’s website is not incorporated by reference into this press release.

 

 

 

Forward-Looking Statements

 

This press release contains forward-looking statements within the meaning of the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements in this press release include, but are not limited to, statements regarding: the expected completion of NewGen's acquisitions of equity interests in K25.ai and the resulting aggregate ownership of 13%; the implied valuation of K25.ai and the corresponding value of NewGen's stake and expected unrealized gain; the anticipated completion of the previously announced issuance of Class A ordinary shares and its expected effect on total shares outstanding and market capitalization; and characterizations of the Company's financial position, balance sheet strength, and growth trajectory in connection with the K25.ai investment.

 

These forward-looking statements are based on the Company's current expectations, estimates, projections and assumptions as of the date of this press release and are subject to known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to differ materially from those expressed or implied. These risks and uncertainties include, among others: the risk that the acquisitions of equity stakes in K25.ai are not completed on the terms described or at all; the risk that the carrying value of the Company's investment in K25.ai is not realized and may be impaired; and share dilution and capital markets issuance risk. Additional risks are described in the Company's Annual Report on Form 20-F and other filings with the U.S. Securities and Exchange Commission.

 

All information provided in this press release is as of the date of this press release. The Company undertakes no obligation to update or revise any forward-looking statements, except as required by applicable securities laws.

 

Contacts

 

ICR, LLC

Robin Yang

Phone: +1 (212) 537-3847

Email: Newgenivf.IR@icrinc.com

 

 

Filing Exhibits & Attachments

1 document